Verify current applicability: The billing team should confirm whether this Aetna policy bulletin (CPB 0185, reviewed 2026-10-20) has been implemented or superseded in your practice's billing system and contracts. Cross-reference the listed covered CPT codes (19316, 19318, 19325, 19328, 19330, 19340, 19342, 19350, 19355, 19357, 19361, 19364, 19367, 19368, 19369, 19370, 19371, 19380, 19396, and others) and approved acellular dermal matrices (Alloderm, Cortiva, DermACELL, DermaMatrix, FlexHD, Strattice, SurgiMend) against your current prior authorization protocols and fee schedules. Ensure that experimental procedures listed (Artia Reconstructive Tissue Matrix, Biodesign Nipple Reconstruction, SimpliDerm, 3D volumetric imaging, venous super-charging) are flagged as non-covered in billing software. Note plan-specific exceptions stated in the policy: 'Many Aetna plans specify that certain surgeries are not considered cosmetic (e.g., surgery to correct injury, post-mastectomy breast reconstruction, breast augmentation to treat gender dysphoria)—check benefit plan descriptions for details.' No deadline is stated; this is routine policy documentation. No specific consequences are stated for non-compliance beyond standard denial protocols.